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Introduction: With the rise in childhood obesity, an increase in the number of patients seeking adolescent
breast reduction has been appreciated. This study examines our experience with presenting symptoms,
techniques, and both surgical and pathologic outcomes for reduction mammaplasty in the adolescent
population.
Methods: Medical records of 76 consecutive patients under 18 years of age who underwent reduction
mammaplasty over a 10 year period were identiﬁed and reviewed for BMI, symptoms, comorbidities,
cancer history, surgical technique, resection weight, pathologic ﬁndings, and complications. Pathology
costs were determined from billing records.
Results: Operative indications included neck, back, and/or shoulder pain (75%), intertrigo (8%), shoulder
grooving (17%), difﬁculty ﬁnding bras (8%) and participating in sports (9%), and social distress (24%).
Average BMI was 31 kg/m2 and 65% of children were obese (BMI > 30). Surgical techniques included
Wise pattern (93%) and superior pedicle (7%). Complications occurred in 8 patients (10.5%). Pathologic
examination yielded no cancers with 80% normal or mildly ﬁbrotic and 20% benign histology. Per breast
reduction specimen, pathology internal costs and external costs by Medicare data averaged $65 and $118,
respectively.
Conclusions: Adolescent mammaplasty patients present symptoms mirroring those of the adult pop-
ulation but also exhibit greater obesity, physical strain, social distress, and comorbid psychiatric disor-
ders. Literature reports similar complication rates for adults as we found in our adolescent population.
We recommend that surgeons strongly consider reduction mammaplasty in the carefully selected
adolescent with macromastia, with realistic expectations and complications in this burgeoning group.
Routine pathologic examination, however, is not a cost effective goal.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Reduction mammaplasty is commonly performed to address
symptoms related to macromastia.1,2 The etiology of macromastia
in pubertal and parapubertal females is variable and includes
endocrine changes, childhood obesity, and juvenile (virginal)
hypertrophy of the breast.3e5 Clearly, the hormonal inﬂuences,
including estrogen receptor hypersensitivity, on breast develop-
ment are complex and have been discussed elsewhere.6,7 Beneﬁts
of reduction mammaplasty include resolution of pain, improved
quality of life, extroversion, and emotional stability.8 Previous work
has focused on reduction mammaplasty outcomes in populations
greater than 18 years of age; however, little is known regarding
outcomes for a growing number of adolescent females seeking
breast reduction.9e12ciates Ltd. Published by Elsevier LtAdolescents requesting reduction mammaplasty require special
considerations given the procedure’s relation to future sequelae
such as decreased nipple sensation, ability to lactate, breast changes
after pregnancy, and mammographic evaluation,13,14 coupled with
the procedure’s permanence.15 Medical comorbidities such as
childhoodobesity, bulimia nervosa, andbody image issuesmust also
be considered.15e17 Taken together, these considerations make an
informed choice regarding surgical intervention vitally important.
Surgical intervention may be warranted in the adolescent pop-
ulation depending upon severity of symptoms and patient quality
of life. Breast hypertrophy should be addressed when it leads to
extreme embarrassment, unwanted attention from boys, psycho-
logic difﬁculties, severe neck and back pain, kyphotic posture,
headaches (due to neck strain), dermatitis and ulceration, breast
tissue necrosis, stretching and ﬂattening of the areola, difﬁculty
with desired activities, problems ﬁnding clothes that ﬁt, brachial
plexus-induced paresthesias, thoracic compression leading to
respiratory distress, and increased spinal curvature for massively
enlarged breasts.18 Beyond addressing patient concerns of pain andd. All rights reserved.
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rare conditions such as benign phyllodes tumors19 and juvenile
breast hypertrophy.20e23
With the heightened social, psychological, and physical strains
of adolescent macromastia, surgeons should consider reduction
mammaplasty as a therapeutic option for this unique population.
Here we discuss the largest known study to date of the indications,
evaluation, surgical approach, and special considerations of the
female adolescent seeking breast reduction surgery.
2. Methods
The Division of Plastic Surgery billing records were searched for reduction
mammaplasty Current Procedural Terminology (CPT) and International Statistical
Classiﬁcation of Diseases and Related Health Problems (ICD9) codes between the
years 1999 and 2009. Identiﬁed patients were then sorted by gender and date of
birth. The medical records of only female patients under the age of 18 at the time of
surgery was chosen for examination. Ofﬁce and electronic charts were reviewed for
Body Mass Index (BMI), presenting symptoms (including back, neck, and shoulder
pain; shoulder grooving; intertrigo; difﬁculty ﬁnding bras; and inability to play
sports), comorbidities (including social distress), cancer history (including family
history), breast characteristics (pre-operative size, asymmetry, ptosis grade, sternal
notch to nipple measurements, and nipple to inframammary fold distance) and
complications. Social distress included only physician-diagnosed and treated
psychiatric problems (e.g., anxiety, Post-Traumatic Stress Disorder (PTSD),
depression).
A personal pregnancy history was also recorded, including patients’ intent to
breastfeed in the future. Operative notes and pathology reports were reviewed for
technique, complications, resection weights and both gross and microscopic path-
ologic ﬁndings. Internal costs of pathologic screening consisted of space, specimen
processing, pathologic examination, and transcription costs. External costs paid by
third parties were determined by reviewing billing records in the Department of
Surgical Pathology.
Categorical variables (pre-operative breast size and ptosis grade) were
compared with BMI using Chi-Square analysis. Continuous variables (sternal notch
to nipple distance, nipple to inframammary fold distance, and resection weights)
were analyzed for association with BMI using linear regression. Statistical signiﬁ-
cance was achieved with p < 0.05. Attempts to employ multivariate analysis for
stratiﬁcation of risk factors for complications were limited by a small sample size.
3. Results
Over a seven-year period from 2002 to 2009, 76 consecutive
adolescent (ages 13e18) patients underwent breast reduction, with
an average age of 16 years and 5 months. These patients had an
average BMI of 34 kg/m2 and 65% were obese (BMI > 30). Self-
reported presenting symptoms included neck, back and/or
shoulder pain (50), intertrigo (7), shoulder grooving (14), difﬁculty
ﬁnding bras (6), and difﬁculty participating in sports (7). Social
distress was reported in 29% of patients. Seven patients reported
a family history positive for breast cancer; however no patients had
a personal history of breast malignancy.
The average pre-operative bra cup size was DDD. Asymmetry
was reported in 83% of patients; 78% of patients had grade 2 or 3
ptosis. Average sternal notch to nipple (SN:N) measurement was
26.2 cm (4.8 cm) with an average difference between breasts of
2.8 cm (1.1 cm). The average nipple to inframammary fold distance
(N:IMF) was 12.8 cm (1.1) with an average difference between
breasts of 0.7 cm (0.4). SN:N and N:IMF measurements did not
signiﬁcantly correlate with patient BMI with corresponding
p values of 1.6 and 0.88 respectively.
Surgical correction was approached through a standard inferior
pedicle Wise pattern technique in 91% of patients; 8% were cor-
rectedwith a superior pedicle technique. Notably, 65% of the last 20
patients (n ¼ 13) were corrected with a superiormedial pedicle-
based reduction. Postoperative complications were reported in 8
patients (10.5%). These complications included 4 partial wound
dehiscences, 3 seromas, 2 cases of cellulitis, and 1 partial nipple
loss. All of these patients were managed without return to the
operating room. No complications were able to be attributed tomedical comorbidities in univariate or multivariate regression
analysis due to our limited sample size.
The average resection weights were 743.3 g and 762.5 g on the
right and left breasts, respectively. Review of breast pathology
revealed no malignant transformations. Normal to mildly ﬁbrotic
disease was seen in 80% (n ¼ 61) of patients and 20% (n ¼ 15) had
benign pathology consisting of ﬁbroadenoma, ﬁbrocystic change, or
ductal hyperplasia without atypia. These diagnoses carried an
average internal cost of $65 and external cost of $118 (Medicare data)
per reduction specimen. The Department of Pathology received
average reimbursements $50 per breast reduction specimen.4. Discussion
The United States faces an adolescent obesity epidemic e the
incidence of obesity tripled between 1970 and 2000, with
concomitant increases of 3.6e49.7% in metabolic syndrome among
severely obese children.24 In the 20th century, dramatic decreases
in the average ages of menarche and thelarche link strongly to
childhood obesity,25 fast food consumption, and decreasing phys-
ical activity.26 Among obese girls, precocious breast development
and higher Dehydroepiandrosterone sulfate (DHEAS) levels are
evident,10 along with a two- to nine-fold increase in mean free
testosterone and hyperinsulinemia27; increased leptin may be
responsible for rises in these adrenal androgen levels.28 Infant
nutrition is associated with subsequent developmental abnormal-
ities, including insulin resistance, exaggerated adrenarche, and
accelerated pubertal development.29 Infant BMI at 36 months may
project future obesity and helps identify those at risk for early
puberty.30 Tadiparthi has described using BMI in assessing patients
for breast reduction surgery.31 As BMI increases and the age of
pubertal onset decreases, we hypothesize that there will be greater
numbers of adolescents with macromastia seeking mammaplasty
for symptomatic relief.
It goes without saying that when obesity is the underlying cause
of macromastia, every effort should be made to lose weight prior to
undergoing breast reduction surgery. While there is no known
publication objectively addressing outcomes of reduction in breast
size following weight loss, it stands within reason that some size
reduction will occur. Depending on the size of the breast, further
reduction through surgery may ultimately still be necessary; if
nothing else than to correct ptosis, skin excess, or areola widening.
Our group has recently shown in the adult massive weight loss
population (>50 lbs) that women who undergo breast reduction
surgery prior to weight loss go on to lose more weight than those
who attempt weight loss ﬁrst. This suggests that women are often
unable to exercise with their current breast size secondary to neck,
back, or shoulder pain, and/or embarrassment with exercise.
Therefore, the ability to exercise with the patients current breast
size must be considered.
Obese patients have higher complication rates than their coun-
terparts with normal body weight, evidenced by the relationship
between specimen weight per breast and subsequent complica-
tions,32 as well as a correlation between BMI and delayed wound
healing.33 Moreover, beyond the symptoms of macromastia shared
by adult patients, there are special considerations in the young
population, including future lactational success, nipple sensation,
changes in breast morphology upon subsequent pregnancy, and
weight loss or gain, the last of which our institution is currently
investigating. While these issues are commonly associated with
females, it must also be mentioned that adolescent males with
gynecomastia possessmany of the same disabilities. This discussion
is outside the scope of this manuscript as techniques and outcomes
are often not comparable between genders for differing reasons.
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controversial due to continued breast tissue growth with matura-
tion, the permanence of the procedure, and the potential devel-
opment of complications. Unfortunately, secondary breast growth
may lead to symptom recurrence. While the majority of patients
may demonstrate varying degrees of breast tissue re-growth,
symptomatic relief and long-term patient satisfaction persist 6
years following surgical intervention; 94% of patients would
undergo their procedure again.34 In addition, one must consider
well-established psychiatric implications of obesity and macro-
mastia, including depression and bulimia nervosa.16,35 Adolescent
patients have been previously described with body-image disor-
ders and concomitant macromastia.16,17 These patients report
improved physical symptoms with reduction mammaplasty (pain,
posture, exercise tolerance) and are better able to ﬁnd appropri-
ately ﬁtting clothes. In a series by Losee et al., 6 patients had greatly
reduced or completely eliminated their eating disorder symptoms
post-reduction mammaplasty and had markedly improved body
image.16 Whether these issues are resolved in our population
following breast reduction remains to be determined, but our
preliminary, short-term follow-up results are promising, with
dissemination of this data in the near future. High rates of patient
satisfaction coupled with relatively low rates of complications
demonstrate that reduction mammaplasty is a safe and reliable
option for the symptomatic adolescent patient with macromastia.
A major concern with adolescent mammaplasty reduction has
been postoperative lactation. In a study following 334 patients after
inferior pedicle reduction mammaplasty, 78 patients delivered
children, 15 breastfed exclusively, and 8 breastfed with formula
supplementation. Forty-one (52.6%) never attempted to breastfeed
and 14 patients were unsuccessful at breastfeeding. Of those 41
who did not breastfeed, 31 had breast engorgement and lactation;
19 reported they would have been able to breastfeed if they had so
chosen to do so.36 In 2007, Cruz et al. did not ﬁnd a signiﬁcant
association between superiorly, medially, or inferiorly-based
reduction mammaplasties and lactational performance; however,
nipple sensation was impaired or absent in 2% of patients.37 The
rate of breastfeeding success was similar among patients with
medial pedicle vertical reductions and womenwithout prior breast
surgery.38 Rather than operative technique or adequate subareolar
tissue preservation, healthcare provider encouragement was most
predictive of breastfeeding success.39 Regardless, the patient must
always be cautioned of the potential inability to breastfeed.
Superior pedicle approaches are increasingly being employed
for reduction mammaplasty in both adult and adolescent pop-
ulations. Studies cite high patient satisfaction and long-term
preservation of breast shape with low complication rates or need
for revision.40 The superomedial pedicle is safe and reliable for
large resections as seen with gigantomastia patients (macromastia
exceeding 1 kg).41 Vertical scar reduction mammoplasty consis-
tently produces a more aesthetic breast shape, leaving less scarring
and greater superior pole fullness than traditional inferior pedicle
approaches employing Wise pattern incisions.42 A lingering criti-
cism of this approach, however, is inadequacy of resection, given
difﬁculty gauging the ultimate long-term aesthetic result when
faced with the characteristic exaggerated appearance of the
resected breast in the operating room. Incision placement is crucial
in the approach to adolescent mammaplasty reduction; scars
should be minimized whenever possible.43
The composition of adult macromastic breast is primarily
adipose tissue,44 and over 60% of specimens demonstrate histo-
logical abnormalities at the time of reduction mammaplasty.45 In
a study of 1289 breast reduction specimens, 2% showed uncertain
malignant potential, 0.3% demonstrated ductal carcinoma in situ,
and 0.1% contained invasive carcinoma (range 14e78 years, mean36.8 years). Dotto et al.46 showed that advanced age increased the
risk for malignancy e patients over 40 years of age should receive
pre-operative mammography, specimen orientation, and margin
inking with one color.47 However, Dehner et al.48 conclude that
ﬁbroadenomas comprise the majority of pediatric breast masses
and that malignant breast tumors are likely to be metastatic or
secondary in origin. Patients younger than 35 with intraductal
papillomas may be at increased risk for future malignancy.49,50
Based on the cost determined by our pathologic review and
incidence of breast malignancy from United States in patients
under the age of 18(0.08 cases per 100,000), the resulting cost of
one breast cancer diagnosis in all mammaplasty specimens is
approximately $147million. Given the extremely low rates of occult
malignancy and high rate of benign lesions in younger patient
populations, the role for routine pathologic specimen evaluation
remains unclear. Ishag et al. examined adult breast reduction
specimens from 560 patients spanning an 11.5 year period and
calculated a cost of $44,000 to identify 4 patients with carcinoma
and 8 with atypical hyperplasia. All of their patients with either
carcinoma or atypical hyperplasia were older than 40 years.51
Clearly, the literature demonstrates that screening pathology
exhibits high speciﬁcity but low sensitivity for diagnosis of malig-
nancy, with large volumes of resection needed for a single diag-
nosis, coupled with a low pre-test probability for malignancy.5. Conclusions
Adolescent macromastia can be a deforming, distressing, and
disabling condition. Presenting symptoms of adolescent mamma-
plasty patients mirror those seen in the adult population. However,
compared to historic controls for the adult population, the adoles-
cent populationdisplays greater obesity andpresentswith increased
social distress and comorbid psychiatric disorders. Complication
rates in the adolescent population are similar to those suggested by
theadult literature. Furthermore, due to the extremely low incidence
of occultmalignancy in theadolescent population, the cost of routine
pathologic examination represents an unneeded healthcare expen-
diture. Thus, surgeons should feel comfortable and obliged to
perform reduction mammaplasty in the carefully selected adoles-
cent patient, where with proper consent and expectations for
complications, surgery may help alleviate the increased social,
psychological, and physical strain caused by macromastia.Conﬂicts of interest
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